135 related articles for article (PubMed ID: 2210377)
1. Induction by HMBA and DMSO of genes introduced into mouse erythroleukemia and other cell lines by transient transfection.
Campbell PL; Kulozik AE; Woodham JP; Jones RW
Genes Dev; 1990 Jul; 4(7):1252-66. PubMed ID: 2210377
[TBL] [Abstract][Full Text] [Related]
2. The LCR-like alpha-globin positive regulatory element functions as an enhancer in transiently transfected cells during erythroid differentiation.
Pondel MD; George M; Proudfoot NJ
Nucleic Acids Res; 1992 Jan; 20(2):237-43. PubMed ID: 1741249
[TBL] [Abstract][Full Text] [Related]
3. Butyrate induces expression of transfected human fetal and endogenous mouse embryonic globin genes in GM 979 erythroleukemia cells.
Zhang JW; Raich N; Enver T; Anagnou NP; Stamatoyannopoulos G
Dev Genet; 1990; 11(2):168-74. PubMed ID: 2379328
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
5. Beta globin gene transcripts originating in the promoter region during early hexamethylene bisacetamide and dimethylsulfoxide induction of Friend erythroleukemia cells.
Weidner DA; Winicov I
Mol Cell Biochem; 1989 Oct; 90(2):175-83. PubMed ID: 2586497
[TBL] [Abstract][Full Text] [Related]
6. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
7. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
Chen Z; Banks J; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):471-5. PubMed ID: 6952199
[TBL] [Abstract][Full Text] [Related]
8. Relationship between globin mRNA accumulation and commitment to terminal cell differentiation in inducer sensitive and resistant erythroleukemia variants.
Weich N; Marks PA; Rifkind RA
Blood; 1990 Jul; 76(2):302-6. PubMed ID: 2369636
[TBL] [Abstract][Full Text] [Related]
9. Gene expression during terminal differentiation: dexamethasone suppression of inducer-mediated alpha 1- and beta maj-globin gene expression.
Kaneda T; Murate T; Sheffery M; Brown K; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5020-4. PubMed ID: 3860841
[TBL] [Abstract][Full Text] [Related]
10. Activation of transiently transfected reporter genes in 3T3 Swiss cells by the inducers of differentiation/apoptosis--dimethylsulfoxide, hexamethylene bisacetamide and trichostatin A.
Ishiguro K; Sartorelli AC
Eur J Biochem; 2004 Jun; 271(12):2379-90. PubMed ID: 15182353
[TBL] [Abstract][Full Text] [Related]
11. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
[TBL] [Abstract][Full Text] [Related]
12. Regulation of murine alpha-, beta major-, and beta minor-globin gene expression.
Weich N; Marks PA; Rifkind RA
Biochem Biophys Res Commun; 1988 Jan; 150(1):204-11. PubMed ID: 2827666
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of expression of a mouse alpha-globin gene by plasmids that include antisense oligonucleotides.
Yokoyama K; Hou DX; Gao H; Tang X; Kitabayashi I; Nishikura K; Gachelin G
Cell Struct Funct; 1992 Dec; 17(6):433-42. PubMed ID: 1295698
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of alpha- and beta-globin messenger RNAs in mouse erythroleukemia cells.
Nudel U; Salmon J; Fibach E; Terada M; Rifkind R; Marks PA; Bank A
Cell; 1977 Oct; 12(2):463-9. PubMed ID: 912753
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of chemical inducers on expression of beta globin genes in murine erythroleukemia cells.
Nudel U; Salmon JE; Terada M; Bank A; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1100-4. PubMed ID: 265555
[TBL] [Abstract][Full Text] [Related]
16. Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment.
Murate T; Kaneda T; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3394-8. PubMed ID: 6203120
[TBL] [Abstract][Full Text] [Related]
17. Gene expression in murine erythroleukemia cells. Transcriptional control and chromatin structure of the alpha 1-globin gene.
Sheffery M; Marks PA; Rifkind RA
J Mol Biol; 1984 Feb; 172(4):417-36. PubMed ID: 6319718
[TBL] [Abstract][Full Text] [Related]
18. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
19. Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division.
Ramsay RG; Ikeda K; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6849-53. PubMed ID: 3462732
[TBL] [Abstract][Full Text] [Related]
20. Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells.
Michaeli J; Lebedev YB; Richon VM; Chen ZX; Marks PA; Rifkind RA
Mol Cell Biol; 1990 Jul; 10(7):3535-40. PubMed ID: 1972544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
